Barry L. Alpert

Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.

Jeffrey L. Anderson, Edward M. Gilbert, Barry L. Alpert et al. · Circulation · 1989 · 291 citations

Heart Failure, Transtelephonic Monitoring, Pharmacotherapy +21

Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study

Anil K. Bhandari, Jefferey L. Anderson, Edward M. Gilbert et al. · American Heart Journal · 1992 · 107 citations

Electrophysiological Evaluation, Cardiovascular Disease, Supraventricular Tachycardia +10

Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias

Sanjeev Saksena, Maria Poczobutt-Johanos, LON W. CASTLE et al. · Journal of the American College of Cardiology · 1992 · 102 citations

Cardiogenic Shock, Device Therapy, Malignant Ventricular Tachyarrhythmias +7

Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.

Richard W. Henthorn, A.L. Waldo, Jeffrey L. Anderson et al. · Circulation · 1991 · 96 citations · Full text

Placebo Phase, Hypertension, Cardiac Anaesthesia +14

The nature and prevalence of the abnormal exercise electrocardiogram in mitral valve prolapse

Peter J. Engel, Barry L. Alpert, James R. Hickman · American Heart Journal · 1979 · 32 citations

Electrophysiological Evaluation, Mitral Valve Prolapse, Kinesiology +12